MedPath

TIANJIN XINXING BACITRACIN METHYLENE DISALICYLATE 11% W/W GRANULAR

Registration Number: MAL15110101HA

Approved
Approval ID

4e83e13176c97906

Registration Number

MAL15110101HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

25.00 mcg/mLAvailable
Package Size: 25.00 mcg/mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

BACITRACIN METHYLENE DISALICYLATEActive
Monograph: bacitracin methylene disalicylate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TIANJIN XINXING BACITRACIN METHYLENE DISALICYLATE 11% W/W GRANULAR - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform